Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

MIST
Milestone Pharmaceuticals Inc. Common Shares
stock NASDAQ

Market Open
Aug 11, 2026 12:36:24 PM EDT
1.25USD0.000%(0.00)396,880
1.25Bid   1.26Ask   0.01Spread
Pre-market
Aug 11, 2026 9:25:30 AM EDT
1.28USD+2.400%(+0.03)15,850
After-hours
Aug 10, 2026 4:53:30 PM EDT
1.25USD-0.271%(0.00)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 4, 2022
07:00AM EST  Milestone Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT Virtual   PR Newswire
Nov 15, 2021
10:53AM EST  Milestone Pharmaceuticals Announces Presentation Of Heart Rate Analysis Of NODE-301 Trial Of Etripamil In Patients With PSVT   Benzinga
10:37AM EST  The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More   Benzinga
07:12AM EST  Milestone Announces Presentation Of Heart Rate Analysis Of NODE-301 Trial Of Etripamil In Patients With PSVT   RTTNews
07:02AM EST  Milestone Pharmaceuticals Announces Presentation of Heart Rate Analysis of   PR Newswire
Nov 12, 2021
07:25AM EST  Milestone Pharmaceuticals Q3 EPS $(0.34) Up From $(0.40) YoY   Benzinga
07:20AM EST  Milestone Pharmaceuticals Reports Third Quarter 2021 Financial Results and   PR Newswire
Nov 11, 2021
07:00AM EST  Milestone Pharmaceuticals to Present at Upcoming Investor Conferences   PR Newswire
Sep 22, 2021
07:00AM EDT  Milestone Pharmaceuticals to Present at the 2021 Cantor Fitzgerald Virtual   PR Newswire
Sep 7, 2021
07:01AM EDT  Milestone Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global   PR Newswire
Aug 11, 2021
04:29PM EDT  Milestone Pharmaceuticals Q2 EPS $0.02 Up From $(0.53) YoY   Benzinga
04:19PM EDT  Milestone Pharmaceuticals Reports Second Quarter 2021 Financial Results and   PR Newswire
May 26, 2021
07:00AM EDT  Milestone Pharmaceuticals to Present at the Jefferies Virtual Healthcare   PR Newswire
May 17, 2021
02:22PM EDT  Milestone Pharmaceuticals shares were trading higher after the company reported Q1 EPS results up from last year.   Benzinga
01:23PM EDT  Milestone Pharma-Ji Xing Pharma Ink $127M Etripamil Development Agreement For China   Benzinga
07:27AM EDT  Milestone Pharmaceuticals Q1 EPS $(0.30) Up From $(0.67) YoY   Benzinga
07:27AM EDT  Milestone Pharmaceuticals Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China   Benzinga
07:21AM EDT  Milestone Pharmaceuticals Announces Late-Breaker Oral Presentation Of NODE-301 Data At ACC.21   RTTNews
07:15AM EDT  Milestone Pharma Q1 Loss Per Share $0.30 Vs Loss $0.67 Last Year   RTTNews
07:14AM EDT  Milestone Pharma Announces Exclusive License Deal With Ji Xing Pharma To Develop Etripamil For PSVT In Greater China   RTTNews
07:14AM EDT  Milestone Pharmaceuticals Gives an Update on Seconday Endpoints in its Phase 3 NODE-301 Trial   Benzinga
07:02AM EDT  Milestone Pharmaceuticals Announces Late-Breaker Oral Presentation of NODE-301   PR Newswire
07:01AM EDT  Milestone Pharmaceuticals Reports First Quarter 2021 Financial Results and   PR Newswire
07:01AM EDT  Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China   PR Newswire
Mar 29, 2021
05:33PM EDT  Milestone Pharmaceuticals Q4 EPS $(0.23) Up From $(0.75) YoY   Benzinga
05:32PM EDT  Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial   PR Newswire
05:32PM EDT  Milestone Pharma Reports First Patient Enrolled In ReVeRA Study, Phase 2 Trial Of Etripamil In Atrial Fibrillation, Rapid Ventricular Rate   Benzinga
05:30PM EDT  its Phase 2 Trial of Etripamil in Atrial Fibrillation and Rapid Ventricular Rate   PR Newswire
Mar 5, 2021
10:29AM EST  Benzinga's Top Ratings Upgrades, Downgrades For March 5, 2021   Benzinga
06:10AM EST  HC Wainwright & Co. Initiates Coverage On Milestone Pharmaceuticals with Buy Rating, Announces Price Target of $20   Benzinga
Feb 25, 2021
07:01AM EST  Milestone Pharmaceuticals to Present at Upcoming Investor Conferences   PR Newswire
Nov 18, 2020
07:17AM EST  Milestone Pharma Announces First Patient Enrolled In RAPID   RTTNews
07:03AM EST  Milestone Pharmaceuticals Announces First Patient Enrolled In RAPID, A Pivotal Phase 3 Study Of Etripamil In PSVT   Benzinga
07:01AM EST  Milestone Pharmaceuticals Announces First Patient Enrolled in RAPID, a Pivotal   PR Newswire
Nov 13, 2020
07:40AM EST  The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations   Benzinga
07:13AM EST  Milestone Pharmaceuticals Q3 EPS $(0.40) Up From $(0.52) YoY   Benzinga
07:08AM EST  Milestone Q3 Loss/Shr $0.40 Vs Loss $0.52 Prior Year   RTTNews
07:01AM EST  Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and   PR Newswire
Nov 11, 2020
07:01AM EST  Milestone Pharmaceuticals to Present at the Jefferies Virtual London Healthcare   PR Newswire
Oct 23, 2020
07:06AM EDT  Milestone Pharmaceuticals Prices 3,810,097 Unit Offering $5.25 Per Unit   Benzinga
07:06AM EDT  Milestone Pharma Announces Pricing Of Public Offering Of $45 Mln Of Common Shares And Pre-Funded Warrants   RTTNews
07:00AM EDT  Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million   PR Newswire
Oct 22, 2020
04:03PM EDT  Milestone Pharmaceuticals Announces Proposed Public Offering Of Common Shares And Pre-Funded Warrants, Terms Not Disclosed   Benzinga
04:02PM EDT  Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares   PR Newswire
Sep 22, 2020
07:07AM EDT  Milestone Pharma Appoints Lisa Giles And Robert Wills To Board, Effective October 1   RTTNews
07:01AM EDT  Milestone Pharmaceuticals Appoints Lisa Giles And Robert Wills To Its Board   RTTNews
07:01AM EDT  Milestone Pharmaceuticals Strengthens Board of Directors with Two New   PR Newswire
Sep 8, 2020
07:00AM EDT  Milestone Pharmaceuticals to Present at Upcoming Investor Conferences   PR Newswire
Aug 12, 2020
07:15AM EDT  Milestone Pharma Q2 Loss Per Share $0.53 Vs Loss $1.04 Last Year   RTTNews
07:03AM EDT  Milestone Pharmaceuticals Q2 EPS $(0.53) Up From $(1.04) YoY   Benzinga
07:00AM EDT  Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and   PR Newswire
Aug 6, 2020
07:00AM EDT  Milestone Pharmaceuticals to Present at the Canaccord Genuity 40th Annual   PR Newswire
Jul 29, 2020
08:32AM EDT  Oppenheimer Upgrades Milestone Pharmaceuticals to Outperform, Announces $18 Price Target   Benzinga
Jul 24, 2020
02:19PM EDT  Juggling Risk And Reward In A Raucous Market   Benzinga
08:13AM EDT  10 Biggest Price Target Changes For Friday   Benzinga
05:54AM EDT  Jefferies Upgrades Milestone Pharmaceuticals to Buy, Raises Price Target to $15   Benzinga
Jul 23, 2020
04:45PM EDT  04:45 Thursday, July 23, 2020   RTTNews
03:52PM EDT  Milestone Pharmaceuticals Shares Up 163%; Hearing Cowen Moves Price Target To $12, Gives Positive Note   Benzinga
03:15PM EDT  Mid-Afternoon Market Update: Dow Tumbles 400 Points; Milestone Pharmaceuticals Shares Gain   Benzinga
12:10PM EDT  Mid-Day Market Update: Brightcove Surges On Upbeat Q2 Results; Aurinia Pharmaceuticals Shares Slide   Benzinga
10:30AM EDT  Shares of Milestone Pharmaceuticals Inc. (MIST) are surging more than 148 percent or $4.96 in Thursday's morning trade at $8.30.   RTTNews
10:13AM EDT  Mid-Morning Market Update: Markets Down; AT&T Earnings Beat Estimates   Benzinga
08:26AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Thurs., Jul. 23, 2020: AMD, NKLA, MIST, ANNX, INOV   Benzinga
07:17AM EDT  Milestone Pharma Announces Regulatory Guidance And Updated Clinical Development Plan For Etripamil In PSVT   RTTNews
07:14AM EDT  Milestone Pharma Reports $25M Private Placement, Expected To Fund Planned Operations In Q2'22   Benzinga
07:13AM EDT  UPDATE: Milestone Pharma Reports NODE-301B Will Reopen To Enrollment, Incorporate Repeat Dosing Regimen, Sees Results Expected In Late 2021/Early 2022   Benzinga
07:12AM EDT  UPDATE: Milestone Pharma Reports NODE-301, NODE-301B Studies Can Be Used As 2 Efficacy Studies Supporting Future New Drug Application Submission   Benzinga
07:07AM EDT  Milestone Pharmaceuticals Announces Regulatory Guidance And Updated Clinical Development Plan For Etripamil In PSVT   Benzinga
07:00AM EDT  Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical   PR Newswire
07:00AM EDT  Milestone Pharmaceuticals Announces $25 Million Private Placement   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC